Ongoing Clinical Trials


Completed Clinical Trials

  • A Phase 2 Study to Evaluate the Safety and Efficacy of Escalated and Fixed Doses of AP301 in Comparison With Sevelamer Carbonate to Treat Hyperphosphatemia in Chronic Kidney Disease Patients Receiving Hemodialysis